Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

63 results

Filters applied: . Clear all
Page 1
Flecainide to prevent atrial arrhythmia after patent foramen ovale closure Rationale and design of the randomized AFLOAT study.
Hauguel-Moreau M, Guedeney P, Dauphin C, Auffret V, Marijon E, Aldebert P, Clerc JM, Beygui F, Elbaz M, Khalil WA, Da Costa A, Macia JC, Elhadad S, Cayla G, Brugier D, Silvain J, Hammoudi N, Duthoit G, Vicaut E, Montalescot G; ACTION Study Group. Hauguel-Moreau M, et al. Among authors: vicaut e. Eur Heart J Cardiovasc Pharmacother. 2024 Jan 12:pvad100. doi: 10.1093/ehjcvp/pvad100. Online ahead of print. Eur Heart J Cardiovasc Pharmacother. 2024. PMID: 38216511
The primary endpoint is the percentage of patients with at least one episode of symptomatic or asymptomatic atrial arrhythmia episode (30s) recorded within 3 months after PFO closure on long-term monitoring with an insertable cardiac monitor. Whether 3 months of treatment …
The primary endpoint is the percentage of patients with at least one episode of symptomatic or asymptomatic atrial arrhythmia episode (30s) …
Preliminary results in tracheal replacement using stented aortic matrices for primary extensive tracheal cancer.
Onorati I, Radu DM, Portela AMS, Peretti M, Guiraudet P, Bardet J, Freynet O, Didier M, Uzunhan Y, Chouahnia K, Duchemann B, Bourinet V, Dutau H, Berthet JP, Marquette CH, Tronc F, Sanchez ML, Trésallet C, Fournier C, Vénissac N, Miyara M, Vicaut E, Martinod E. Onorati I, et al. Among authors: vicaut e. JTCVS Tech. 2023 Jun 23;21:227-236. doi: 10.1016/j.xjtc.2023.05.021. eCollection 2023 Oct. JTCVS Tech. 2023. PMID: 37854807 Free PMC article.
OBJECTIVE: Recent studies have demonstrated the feasibility and favorable long-term results of tracheobronchial replacement using stented cryopreserved aortic allografts. ...
OBJECTIVE: Recent studies have demonstrated the feasibility and favorable long-term results of tracheobronchial replacement using ste …
P2Y12 Inhibitor Loading Time Before Elective PCI and the Prevention of Myocardial Necrosis.
Roule V, Beygui F, Cayla G, Rangé G, Motovska Z, Delarche N, Jourda F, Goube P, Guedeney P, Zeitouni M, El Kasty M, Laredo M, Dumaine R, Ducrocq G, Derimay F, Van Belle E, Manigold T, Cador R, Combaret N, Vicaut E, Montalescot G, Silvain J; ALPHEUS Investigators. Roule V, et al. Among authors: vicaut e. Can J Cardiol. 2024 Jan;40(1):31-39. doi: 10.1016/j.cjca.2023.08.028. Epub 2023 Sep 3. Can J Cardiol. 2024. PMID: 37660934
CONCLUSIONS: In elective PCI, administration of the oral P2Y(12) inhibitor at the time of PCI could be associated with more frequent periprocedural myocardial necrosis than an earlier administration. The long-term clinical consequences remain unknown....
CONCLUSIONS: In elective PCI, administration of the oral P2Y(12) inhibitor at the time of PCI could be associated with more frequent peripro …
Effect of atherosclerosis on 5-year risk of major vascular events in patients with transient ischaemic attack or minor ischaemic stroke: an international prospective cohort study.
Lavallée PC, Charles H, Albers GW, Caplan LR, Donnan GA, Ferro JM, Hennerici MG, Labreuche J, Molina C, Rothwell PM, Steg PG, Touboul PJ, Uchiyama S, Vicaut É, Wong LKS, Amarenco P; TIAregistry.org Investigators. Lavallée PC, et al. Among authors: vicaut e. Lancet Neurol. 2023 Apr;22(4):320-329. doi: 10.1016/S1474-4422(23)00067-4. Lancet Neurol. 2023. PMID: 36931807
BACKGROUND: The prevalence of atherosclerosis and the long-term risk of major vascular events in people who have had a transient ischaemic attack or minor ischaemic stroke, regardless of the causal relationship between the index event and atherosclerosis, are not well know …
BACKGROUND: The prevalence of atherosclerosis and the long-term risk of major vascular events in people who have had a transient isch …
βeta blocker interruption after uncomplicated myocardial infarction: rationale and design of the randomized ABYSS trial.
Silvain J, Cayla G, Ferrari E, Range G, Puymirat E, Delarche N, Collet JP, Dumaine R, Slama M, Payot L, Kasty ME, Aacha K, Vicaut E, Montalescot G; ABYSS investigators of the ACTION Study Group,. Silvain J, et al. Among authors: vicaut e. Am Heart J. 2023 Apr;258:168-176. doi: 10.1016/j.ahj.2023.01.014. Epub 2023 Jan 20. Am Heart J. 2023. PMID: 36682596 Clinical Trial.
BACKGROUND: The long-term use of beta-blocker after myocardial infarction (MI) when global left ventricular ejection fraction (LVEF) is preserved has not been studied in the era of modern myocardial reperfusion and secondary prevention therapies. ...
BACKGROUND: The long-term use of beta-blocker after myocardial infarction (MI) when global left ventricular ejection fraction (LVEF) …
Risk of subsequent disabling or fatal stroke in patients with transient ischaemic attack or minor ischaemic stroke: an international, prospective cohort study.
Hobeanu C, Lavallée PC, Charles H, Labreuche J, Albers GW, Caplan LR, Donnan GA, Ferro JM, Hennerici MG, Molina CA, Rothwell PM, Steg PG, Touboul PJ, Uchiyama S, Vicaut E, Wong KSL, Amarenco P; TIAregistry.org Investigators. Hobeanu C, et al. Among authors: vicaut e. Lancet Neurol. 2022 Oct;21(10):889-898. doi: 10.1016/S1474-4422(22)00302-7. Lancet Neurol. 2022. PMID: 36115361
We aimed to assess 5-year functional outcomes in patients with transient ischaemic attack or minor ischaemic stroke and to determine the factors associated with long-term disability. METHODS: We analysed data from patients in TIAregistry.org, an international, prospective, …
We aimed to assess 5-year functional outcomes in patients with transient ischaemic attack or minor ischaemic stroke and to determine the fac …
Airway replacement using stented aortic matrices: Long-term follow-up and results of the TRITON-01 study in 35 adult patients.
Martinod E, Radu DM, Onorati I, Portela AMS, Peretti M, Guiraudet P, Destable MD, Uzunhan Y, Freynet O, Chouahnia K, Duchemann B, Kabbani J, Maurer C, Brillet PY, Fath L, Brenet E, Debry C, Buffet C, Leenhardt L, Clero D, Julien N, Vénissac N, Tronc F, Dutau H, Marquette CH, Juvin C, Lebreton G, Cohen Y, Zogheib E, Beloucif S, Planès C, Trésallet C, Bensidhoum M, Petite H, Rouard H, Miyara M, Vicaut E. Martinod E, et al. Among authors: vicaut e. Am J Transplant. 2022 Dec;22(12):2961-2970. doi: 10.1111/ajt.17137. Epub 2022 Jul 14. Am J Transplant. 2022. PMID: 35778956 Free article.
Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial.
CORIMUNO-19 Collaborative group. CORIMUNO-19 Collaborative group. Lancet Rheumatol. 2022 Jan;4(1):e24-e32. doi: 10.1016/S2665-9913(21)00315-5. Epub 2021 Nov 17. Lancet Rheumatol. 2022. PMID: 34812424 Free PMC article.
Further studies are warranted to evaluate the effect of sarilumab on long-term survival. FUNDING: Assistance publique-Hopitaux de Paris....
Further studies are warranted to evaluate the effect of sarilumab on long-term survival. FUNDING: Assistance publique-Hopitaux de Par …
Efficacy of Severe Acute Respiratory Syndrome Coronavirus-2 Vaccine in Patients With Thoracic Cancer: A Prospective Study Supporting a Third Dose in Patients With Minimal Serologic Response After Two Vaccine Doses.
Gounant V, Ferré VM, Soussi G, Charpentier C, Flament H, Fidouh N, Collin G, Namour C, Assoun S, Bizot A, Brouk Z, Vicaut E, Teixeira L, Descamps D, Zalcman G. Gounant V, et al. Among authors: vicaut e. J Thorac Oncol. 2022 Feb;17(2):239-251. doi: 10.1016/j.jtho.2021.10.015. Epub 2021 Nov 16. J Thorac Oncol. 2022. PMID: 34798306 Free PMC article.
Of the 269 serologic results available beyond day 14 after the second vaccine dose administration, 17 patients (6.3%) were still negative (<50 arbitrary units/mL, whereas 34 (11%) were less than 300 arbitrary units/mL (12.5th percentile). In multivariate analysis, only age (p …
Of the 269 serologic results available beyond day 14 after the second vaccine dose administration, 17 patients (6.3%) were still negative (& …
Early and short-term intensive management after discharge for patients hospitalized with acute heart failure: a randomized study (ECAD-HF).
Logeart D, Berthelot E, Bihry N, Eschalier R, Salvat M, Garcon P, Eicher JC, Cohen A, Tartiere JM, Samadi A, Donal E, deGroote P, Mewton N, Mansencal N, Raphael P, Ghanem N, Seronde MF, Chavelas C, Rosamel Y, Beauvais F, Kevorkian JP, Diallo A, Vicaut E, Isnard R. Logeart D, et al. Among authors: vicaut e. Eur J Heart Fail. 2022 Jan;24(1):219-226. doi: 10.1002/ejhf.2357. Epub 2021 Oct 21. Eur J Heart Fail. 2022. PMID: 34628697 Free article. Clinical Trial.
63 results